• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. VIVA XT; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. VIVA XT; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTBA1D4
Device Problems Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Congestive Heart Failure (1783); Endocarditis (1834); Unspecified Infection (1930); Renal Failure (2041); Respiratory Distress (2045); Sepsis (2067); Shock from Patient Lead(s) (3162)
Event Date 04/21/2015
Event Type  Injury  
Event Description
It was reported the patient developed endocarditis and that there was perforation of the right ventricular lead.The implantable cardioverter defibrillator (icd) was explanted.The patient was enrolled in the (b)(6) clinical study.No further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
The information submitted reflects all relevant data received.If additional relevant information is received, a supplemental report will be submitted.(b)(4).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received and reported that endocarditis was initially suspected however the patient left against medical advice and did not receive a full workup.The patient then was readmitted with respiratory distress, was intubated.The patient was admitted to the hospital with chronic obstructive pulmonary disease exacerbation, congestive heart failure and was then transferred to another hospital for explant.After transfer, the patient was diagnosed with endocarditis, septic emboli, an embolic stroke and renal failure.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was further reported the patient received high voltage therapy for atrial fibrillation with a rapid ventricular response.The patient was treated with medications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIVA XT
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC CARDIAC RHYTHM HEART FAILURE
8200 coral sea st ne
mounds view MN 55112
Manufacturer Contact
lisa robertson
8200 coral sea st ne
mounds view, MN 55112
7635262723
MDR Report Key4969952
MDR Text Key6074606
Report Number3004209178-2015-14875
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative,company representati
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/14/2015
Device Model NumberDTBA1D4
Device Catalogue NumberDTBA1D4
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/07/2019
Date Device Manufactured03/18/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
4196-88 LEAD, 6947M62 LEAD, 5076-52 LEAD
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age00053 YR
-
-